Cargando…

Identification of Phlogacantholide C as a Novel ADAM10 Enhancer from Traditional Chinese Medicinal Plants

Background: Alzheimer’s disease is one of the most prevalent dementias in the elderly population with increasing numbers of patients. One pivotal hallmark of this disorder is the deposition of protein aggregates stemming from neurotoxic amyloid-beta peptides. Synthesis of those peptides has been eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meineck, Myriam, Schuck, Florian, Abdelfatah, Sara, Efferth, Thomas, Endres, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5456242/ https://www.ncbi.nlm.nih.gov/pubmed/28930140 http://dx.doi.org/10.3390/medicines3040030

Ejemplares similares

Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice
por: Prinzen, Claudia, et al.
Publicado: (2009)

Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10
por: Augustin, Regina, et al.
Publicado: (2012)

Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms
por: Endres, Kristina, et al.
Publicado: (2017)

North African Medicinal Plants Traditionally Used in Cancer Therapy
por: Alves-Silva, Jorge M., et al.
Publicado: (2017)

In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library
por: Shahhamzehei, Nasim, et al.
Publicado: (2022)

Cytotoxicity and Pharmacogenomics of Medicinal Plants from Traditional Korean Medicine
por: Kuete, Victor, et al.
Publicado: (2013)

Gems from traditional north-African medicine: medicinal and aromatic plants from Sudan
por: Khalid, Hassan, et al.
Publicado: (2012)

Antiangiogenic Activity and Pharmacogenomics of Medicinal Plants from Traditional Korean Medicine
por: Seo, Ean-Jeong, et al.
Publicado: (2013)

NrCAM is a marker for substrate‐selective activation of ADAM10 in Alzheimer's disease
por: Brummer, Tobias, et al.
Publicado: (2019)

In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database
por: Dai, Shao-Xing, et al.
Publicado: (2016)

Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein
por: Linsenmeier, Luise, et al.
Publicado: (2018)

Corrigendum: In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database
por: Dai, Shao-Xing, et al.
Publicado: (2016)

Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis
por: Lee, David Y.W., et al.
Publicado: (2021)

ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014)

ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
por: Van Meenen, Dario, et al.
Publicado: (2022)

Identification and characterization of deschloro-chlorothricin obtained from a large natural product library targeting aurora A kinase in multiple myeloma
por: Özenver, Nadire, et al.
Publicado: (2020)

Correction to: Identification and characterization of deschloro-chlorothricin obtained from a large natural product library targeting aurora A kinase in multiple myeloma
por: Özenver, Nadire, et al.
Publicado: (2021)

An Exploration of Traditional Chinese Medicinal Plants with Anti-Inflammatory Activities
por: Fan, Chao, et al.
Publicado: (2017)

TCMPG: an integrative database for traditional Chinese medicine plant genomes
por: Meng, Fanbo, et al.
Publicado: (2022)

Assessment of ADAM17 and ADAM10 proteins with CXCL10 and thyroid autoimmunity in vitiligo pathogenesis
por: Kılıc, Sevilay, et al.
Publicado: (2022)

Role of ADAM10 and ADAM17 in Regulating CD137 Function
por: Seidel, Jana, et al.
Publicado: (2021)

Network Pharmacology of Ginseng (Part II): The Differential Effects of Red Ginseng and Ginsenoside Rg5 in Cancer and Heart Diseases as Determined by Transcriptomics
por: Panossian, Alexander, et al.
Publicado: (2021)

Network Pharmacology of Red Ginseng (Part I): Effects of Ginsenoside Rg5 at Physiological and Sub-Physiological Concentrations
por: Panossian, Alexander, et al.
Publicado: (2021)

Network Pharmacology of Ginseng (Part III): Antitumor Potential of a Fixed Combination of Red Ginseng and Red Sage as Determined by Transcriptomics
por: Panossian, Alexander, et al.
Publicado: (2022)

Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP
por: Sammel, Martin, et al.
Publicado: (2019)

Pharmacometrics of 3-Methoxypterostilbene: A Component of Traditional Chinese Medicinal Plants
por: Martinez, Stephanie E., et al.
Publicado: (2013)

Recent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plants
por: Yang, Lei, et al.
Publicado: (2015)

The neuroprotective effect of traditional Chinese medicinal plants—A critical review
por: Moreira, João, et al.
Publicado: (2023)

LRP1 shedding in human brain: roles of ADAM10 and ADAM17
por: Liu, Qiang, et al.
Publicado: (2009)

Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus
por: Del Turco, Domenico, et al.
Publicado: (2014)

Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function
por: Leitzke, Sinje, et al.
Publicado: (2022)

Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris
por: Kugelmann, Daniela, et al.
Publicado: (2022)

Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer’s Disease Target
por: Kaufmann, Dorothea, et al.
Publicado: (2016)

Pharmacologic Inhibition of ADAM10 Attenuates Brain Tissue Loss, Axonal Injury and Pro-inflammatory Gene Expression Following Traumatic Brain Injury in Mice
por: Appel, Dominik, et al.
Publicado: (2021)

Targeting ADAM10 in Cancer and Autoimmunity
por: Smith, Timothy M., et al.
Publicado: (2020)

Is Traditional Chinese Medicine “Mainstream” in China? Trends in Traditional Chinese Medicine Health Resources and Their Utilization in Traditional Chinese Medicine Hospitals from 2004 to 2016
por: Shi, Xuefeng, et al.
Publicado: (2020)

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017)

Traditional Chinese medicine for cancer?
por: Ernst, E
Publicado: (2012)

Identification of tyrosinase inhibitors from traditional Chinese medicines for the management of hyperpigmentation
por: Tang, Hsin-Chieh, et al.
Publicado: (2015)

The identification and molecular mechanism of anti-stroke traditional Chinese medicinal compounds
por: Liu, Jia-Qian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h2pnmnlpf0u0tarkje4kbq93ch